Doubling time of serum CA125 is an independent prognostic factor for survival in patients with ovarian cancer relapsing after first-line chemotherapy.
| Image |  |
|---|---|
| Description | scientific article published on 19 March 2010 |
| Author/s |
author: Vasilis Karavasilis |
| Publication date | March 19, 2010 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |